JTCS Concomitant Website
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to Personal Folders
Right arrow Download to citation manager
Right arrow Permission Requests
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Lee, K. F.
Right arrow Articles by Wechsler, A. S.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Lee, K. F.
Right arrow Articles by Wechsler, A. S.

The Journal of Thoracic and Cardiovascular Surgery, Vol 95, 216-222, Copyright © 1988 by The American Association for Thoracic Surgery and The Western Thoracic Surgical Association


ARTICLES

Immediate versus delayed coronary grafting after streptokinase treatment. Postoperative blood loss and clinical results

KF Lee, J Mandell, JS Rankin, LH Muhlbaier and AS Wechsler
Department of Surgery, Duke University Medical Center, Durham, N.C. 27710.

Of all patients with acute evolving myocardial infarction treated surgically at Duke University Medical Center between 1984 and 1986, 27 patients given high doses (greater than 1.5 million units) of streptokinase preoperatively were studied. Eleven patients who received streptokinase had coronary bypass grafting 12 hours after thrombolytic therapy (early hours), eight patients between 12 and 72 hours (delayed), and eight patients beyond 72 hours (late hours). Seventeen patients who underwent coronary bypass grafting within 6 hours of the onset of symptoms, without preoperative streptokinase, were included as control patients. Only the patients having early operation had significantly greater postoperative blood loss; postoperative use of red blood cells; fresh-frozen plasma; cryoprecipitate; prolonged postoperative prothrombin time; and prolonged partial thromboplastin time. Patients having delayed or late operations did not differ significantly from patients not receiving streptokinase. Only the interval between time of streptokinase administration and operation could account for the coagulopathy and the postoperative bleeding complications in the early group. Patients in the early group had a higher in-hospital mortality (27% versus 6% for the non-streptokinase group) and major noncardiac morbidity (36% versus 12% for the non- streptokinase group). Patients in the delayed and late groups had minimal postoperative complications and no mortality. Observations were not explained by differences in total ischemic time, number of angioplasty failures, or number of patients with cardiogenic shock between the early group and the non-streptokinase group. Postoperative bleeding and massive use of blood products seemed to be contributory factors: Two of three deaths in the patients having early operations were associated with clinical suspicion of tamponade. Patients undergoing coronary bypass grafting within 12 hours of streptokinase therapy appear to be a high-risk group in a more emergent, uncontrolled clinical setting and require aggressive monitoring and correction of coagulopathy.


This article has been cited by other articles:


Home page
J Am Coll CardiolHome page
Y. Shapira, I. Herz, M. Vaturi, A. Porter, Y. Adler, Y. Birnbaum, B. Strasberg, S. Sclarovsky, and A. Sagie
Thrombolysis is an effective and safe therapy in stuck bileaflet mitral valves in the absence of high-risk thrombi
J. Am. Coll. Cardiol., June 1, 2000; 35(7): 1874 - 1880.
[Abstract] [Full Text] [PDF]


Home page
ANN INTERN MEDHome page
L. E. Goldman and M. J. Eisenberg
Identification and Management of Patients with Failed Thrombolysis after Acute Myocardial Infarction
Ann Intern Med, April 4, 2000; 132(7): 556 - 565.
[Abstract] [Full Text] [PDF]


Home page
CLIN APPL THROMB HEMOSTHome page
S. M. Lanzkron and W. R. Bell
State-of-the-Art Review : Management of Patients Who Require Invasive Procedures Immediately Following Thrombolytic Therapy
Clinical and Applied Thrombosis/Hemostasis, July 1, 1996; 2(3): 158 - 163.
[Abstract] [PDF]


Home page
J. Thorac. Cardiovasc. Surg.Home page
J. C. Nicolau, R. V. Ardito, S. A. C. Garzon, M. A. F. V. Pinto, P. R. Nogueira, A. M. Lorga, and J. L. B. Jacob
Surgical revascularization after fibrinolysis in acute myocardial infarctionLong-term follow-up
J. Thorac. Cardiovasc. Surg., June 1, 1994; 107(6): 1454 - 1459.
[Abstract] [Full Text]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
ANN THORAC SURG ASIAN CARDIOVASC THORAC ANN EUR J CARDIOTHORAC SURG
J THORAC CARDIOVASC SURG ICVTS ALL CTSNet JOURNALS
Copyright © 1988 by The American Association for Thoracic Surgery.